Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Evergaze is a private medtech company in Richardson, Texas developing electronic eyewear for people with low vision. Its lead product, seeBOOST, is a lightweight electronic prescription-glasses device designed to improve functional vision in patients with age-related macular degeneration, diabetic retinopathy, and other forms of central vision loss. The system combines optical, semiconductor, and image-enhancement technology with features such as adjustable magnification, autofocus, and automatic contrast enhancement. Evergaze appears to operate primarily as a product-focused medical device company rather than a therapeutics developer, with its business centered on assistive vision technology for ophthalmic patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Evergaze.